Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion type Assertion NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_head.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion description "[At the end of the trial, however, weight gain occurred, and carriers of the T allele developed first hyperglycemia and decreased insulin secretion, which suggests the need for different after-care preventive approaches tailored to each genotype's metabolic risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_provenance.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion evidence source_evidence_literature NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_provenance.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion SIO_000772 19864407 NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_provenance.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion wasDerivedFrom befree-2016 NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_provenance.
- NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_assertion wasGeneratedBy ECO_0000203 NP772308.RADsAd8B4sUDbl-v1agvc53a1m7gcyPIl1ByZ0leytJ-g130_provenance.